Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can we, should we, eradicate the meningococcus?

Vaccine - 30 May 2012

Maiden Martin C J, Frosch Matthias

Abstract excerpt

The eradication of infectious agents is an attractive means of disease control that, to date, has been achieved for only one human pathogen, the smallpox virus. The introduction of vaccines against Neisseria meningitidis into immunisation schedules, and particularly the conjugate polysaccharide v...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Variation
Share to Global Health
Share to Meningococcal Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neisseria meningitidis

Source

Open in PubMed Open full text

Identifiers

PMID: 22607899
DOI: 10.1016/j.vaccine.2011.12.068
PMCID: PMC3366072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22607899-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can we, should we, eradicate the meningococcus?PMID 22607899Read ↗

Bexsero® chronicleSemantic proximity Read ↗

Meningococcal disease: changes in epidemiology and preventionSemantic proximity Read ↗

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective<i>Neisseria meningitidis</i>VaccinesSemantic proximity Read ↗

<i>Neisseria meningitidis</i>B vaccines: recent advances and possible immunization policiesSemantic proximity Read ↗

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidisSemantic proximity Read ↗

BexseroSemantic proximity Read ↗

Genome‑based vaccine development: A short cut for the futureSemantic proximity Read ↗

Genome-based vaccine development: a short cut for the future.Semantic proximity Read ↗

Novel approaches to Neisseria meningitidis vaccine designSemantic proximity Read ↗

Meningococcal serogroup B vaccines: will they live up to expectations?Semantic proximity Read ↗

Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.Semantic proximity Read ↗

Pre-clinical efficacy of a candidate Outer Membrane Vesicle gonococcal vaccine in comparison with 4CMenB.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.